Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Cells

Clinical trial NCT06653777 · RECRUITING

Trial details

NCT number: NCT06653777
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Miscellaneous

Start date: 2025-03-27
Primary completion: 2027-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.